XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Revenues:        
Research and development revenues $ 1,471,819 $ 948,069 $ 2,080,630 $ 1,393,054
Revenues 5,943,898 5,927,469 11,597,518 10,305,597
Expenses:        
Research and development 4,526,156 4,678,221 8,977,809 8,960,090
Selling, general and administration 6,913,503 5,200,261 13,844,913 10,841,947
Total expenses 14,937,409 13,995,708 30,382,663 27,036,620
Loss from operations (8,993,511) (8,068,239) (18,785,145) (16,731,023)
Other income and expense:        
Interest income 165,513 186,142 325,364 419,919
Other income 18,101 65,018 1,119,356 325,430
Foreign currency transaction (losses) gains (235,776) 556,539 (27,168) (634,743)
Gain on investments 0 0 2,849,816 274,000
Total other income and expense (52,162) 807,699 4,267,368 384,606
Loss before (provision) benefit for income taxes and net loss (income) attributable to noncontrolling interest (9,045,673) (7,260,540) (14,517,777) (16,346,417)
Tax (provision) benefit (201,000) 0 (201,000) 1,146,000
Net loss (9,246,673) (7,260,540) (14,718,777) (15,200,417)
Net loss (income) attributable to noncontrolling interest 5,716 (71,431) (58,458) 10,007
Net loss attributable to Kopin Corporation $ (9,240,957) $ (7,331,971) $ (14,777,235) $ (15,190,410)
Net (loss) income per share        
Basic and diluted (usd per share) $ (0.13) $ (0.10) $ (0.20) $ (0.22)
Weighted average number of common shares        
Basic and diluted (in shares) 73,095,253 70,626,542 73,086,752 67,582,615
Product [Member]        
Revenues:        
Research and development revenues $ 1,471,819   $ 2,080,630  
Revenues 4,472,079 $ 4,979,400 9,516,888 $ 8,912,543
Other income and expense:        
Cost of Goods and Services Sold 3,497,750 $ 4,117,226 7,559,941 $ 7,234,583
Net loss attributable to Kopin Corporation $ (9,240,957)   $ (14,777,235)